These discordant observations suggest there is additional nuance to be explored in this area; perhaps that there may be significant variation in the threshold dose for TREX1 activation in different cancers.
← all excerpts
Harnessing the cGAS-STING pathway to potentiate radiation therapy: current approaches and future directions.
1
—
—